Skip to main content
  1. Courses
  2. ISMPP U - ISMPP AI Position...
  3. ISMPP U - ISMPP AI Position...

ISMPP U - ISMPP AI Position Statement and Call to Action - The Time to Act is Now!

Thank you

Artificial Intelligence (AI) is impacting medical publications and communications and will continue to play a pivotal role in reshaping the landscape of our profession and practices.

A new ISMPP Position Statement and Call to Action on Artificial Intelligence will be published in Current Medical Research and Opinion (CRMO) in early November. ISMPP members and all medical publication and communication professionals are encouraged to gain familiarity with and adopt the principles in the ISMPP AI Position Statement and Call to Action.

  • The AI Position Statement urges medical publication and communication professionals to commit to various important elements, including appropriate utilization and disclosure of AI, driving accountability, ensuring responsibility and trust, and maintaining confidentiality, among others.
  • The Call to Action for ISMPP Members spotlights the vital, leading role that ISMPP members should play in becoming educated and trained on AI; implementing and using AI responsibly, transparently, and fairly; and advocating for and actively engaging with AI within and beyond their organizations.

Attend this webinar, presented by co-chairs and members of the ISMPP AI Task Force, to learn about the principles in the ISMPP AI Position Statement and Call to Action, and gain knowledge about various considerations that went into the creation of the principles. Ask questions of the AI Task Force faculty about the AI Position Statement and Call to Action, and the use of AI in medical publications and communications.

Learning Objectives: At the end of this session, attendees will
●Understand the principles of the ISMPP AI Position Statement and Call to Action and their rationale
●Gain knowledge of how to apply the ISMPP AI Position Statement and Call to Action to their own practices and to that of their organization and beyond
●Recognize stakeholders’ responsibilities in deploying and utilizing AI in their environments
●Implement policies and procedures to adopt AI in their environments and enterprises, including supporting training and professional development

Description

This ISMPP U webinar is derived from the ISMPP AI Task Force. Artificial Intelligence (AI) is impacting medical publications and communications and will continue to play a pivotal role in reshaping the landscape of our profession and practices.

A new ISMPP Position Statement and Call to Action on Artificial Intelligence was published in Current Medical Research and Opinion (CMRO) on November 1. ISMPP members and all medical publication and communication professionals are encouraged to gain familiarity with and adopt the principles in the ISMPP AI Position Statement and Call to Action.

  • The AI Position Statement urges medical publication and communication professionals to commit to various important elements, including appropriate utilization and disclosure of AI, driving accountability, ensuring responsibility and trust, and maintaining confidentiality, among others.
  • The Call to Action for ISMPP Members spotlights the vital, leading role that ISMPP members should play in becoming educated and trained on AI; implementing and using AI responsibly, transparently, and fairly; and advocating for and actively engaging with AI within and beyond their organizations.

Attend this webinar, presented by co-chairs and members of the ISMPP AI Task Force, to learn about the principles in the ISMPP AI Position Statement and Call to Action, and gain knowledge about various considerations that went into the creation of the principles. Ask questions of the AI Task Force faculty about the AI Position Statement and Call to Action, and hear their perspectives on the use of AI in medical publications and communications.

Learning Objectives: At the end of this session, attendees will
  • Understand the principles of the ISMPP AI Position Statement and Call to Action and their rationale
  • Gain knowledge of how to apply the ISMPP AI Position Statement and Call to Action to their own practices and to that of their organization and beyond
  • Recognize stakeholders’ responsibilities in deploying and utilizing AI in their environment

Approved for 1 CMPP credit

Contributors

  • Matt Lewis, Global Chief Artificial and Augmented Intelligence Officer, Inizio Medical

    • 25 years in life experiences, with roles in small pharma, private and public-side organizations, not-for-profit professional society, patient advocacy, agency and consultancy organizations
    • Therapeutic area depth in oncology/hematology, neuropsychiatry and rare disorders
    • Founded the Inizio Medical Analytics and Innovation team, with an emphasis on advanced analytics, digital consulting and software as a service digital transformation partnership
    • Practice lead for augmented intelligence across Inizio Medical; lead on the Generative AI workstream for MAPS, lead AI author for HCA’s AI Roadmap (published in CMRO)
    • Executive Lead for Inizio’s Mental Health and Wellbeing Business Employee Resource Group

  • Keith Goldman, Executive Director, Global Scientific Publications, AbbVie

    • 23 years in medical publishing, scientific communications, and launch leadership
    • Spearheaded Artificial Intelligence use in Publications at AbbVie
    • Established Scientific Platforms concept and repository at Allergan
    • Expertise in innovative approaches to strategic publication planning
    • Leadership approach shaped by 10 years with Disney Parks & Events

  • Jennifer Ghith, Senior Director, Omnichannel Strategy and Innovations Lead, Global Scientific Communications, Pfizer

    • > 15 years of experience in Industry and scientific communications
    • Leads implementation of cross-portfolio omnichannel strategies that amplify emerging data across publications, congresses and digital platforms
    • 5 years of experience with AI, with research published in peer-reviewed journals and presented at national as well as international meetings
    • ISMPP Board of Trustees member, MAPS Digital Focus Area Working Group Member, MBA Candidate

  • Amy Foreman-Wykert, Executive Director, Scientific Communications, Inflammation Therapeutic Area, Amgen Inc.

    • 18 years of experience in scientific publication writing, editing, planning, and team leadership
    • Fosters innovation and best practices to advance scientific communication capabilities
    • Participant in Amgen AI task force

  • Valerie Moss, Chief Scientific Officer, Prime

    • 25 years in medical communications, with a passion for science and innovation
    • Oversees Prime’s excellence team to ensure our commitment to scientific accuracy and integrity
    • A leader of Prime’s AI working group and provided oversight of our Generative AI standard operating procedure

  • Moderator: Jason Gardner, SVP, Head of Medical, Real Chemistry

    • Excited about embracing AI responsibly in all that we do, while still putting people at the centre of the strategic process
    • Passionate in bringing clarity to communications – for all audiences
    • Using insights-driven approaches to research optimal formats and channels of communication
    • Chair of the program committee for the forthcoming ISMPP annual meeting (spoiler alert – AI might feature on the agenda!)

November 8, 2023
Wed 11:00 AM EST

Duration 1H 0M

This live web event has ended.

You can access this item by buying entire course

Buy entire course:

ISMPP U Support
ismpp@ismpp.org